Comparison of Intermittent vs. Continuous Walking in MS
NCT ID: NCT02726373
Last Updated: 2016-04-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
12 participants
INTERVENTIONAL
2013-01-31
2014-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
High Intensity Interval Gait Training in Multiple Sclerosis
NCT05560880
High Intensity Interval Gait Training in Multiple Sclerosis
NCT05529498
Effect of High Intensity Training on Motor and Cognitive Functions
NCT06219304
High-Intensity, Dynamic-stability Gait Training in People With Multiple Sclerosis
NCT05735691
Effects of High-intensity Gait Training on Fatigue, Gait, and Neuroplasticity in People With Multiple Sclerosis
NCT06264336
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intermittent walking training
type of walking
Subjects walked either intermittently or continuously twice a week for 4 weeks, then crossed over
Continuous Walking Training
type of walking
Subjects walked either intermittently or continuously twice a week for 4 weeks, then crossed over
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
type of walking
Subjects walked either intermittently or continuously twice a week for 4 weeks, then crossed over
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Ambulatory for at least 6 minutes with or without an assistive device (e.g. cane, crutches or orthotics)
* Ability to read, understand, and sign an informed consent form
Exclusion Criteria
* Orthopedic or cardiovascular condition that would interfere with ability to walk for 6 continuous minutes,
* Currently being on an active physical rehabilitation program
18 Years
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hunter College of City University of New York
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Herb Karpatkin
Assistant Professor
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
INTCON1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.